0001140361-13-014961.txt : 20130401
0001140361-13-014961.hdr.sgml : 20130401
20130401194603
ACCESSION NUMBER: 0001140361-13-014961
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130328
FILED AS OF DATE: 20130401
DATE AS OF CHANGE: 20130401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Allen Russell Glenn
CENTRAL INDEX KEY: 0001523950
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 13732961
MAIL ADDRESS:
STREET 1: C/O HANGER ORTHOPEDIC GROUP, INC.
STREET 2: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2013-03-28
0
0000722723
HANGER, INC.
HGR
0001523950
Allen Russell Glenn
10910 DOMAIN DRIVE, SUITE 300
AUSTIN
TX
78758
0
1
0
0
VP, Treasurer & Asst. Secy.
Common Stock
2013-03-28
4
S
0
448
31.4385
D
11915
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares.
These shares were sold at a range of sale prices from $31.28 to $31.53. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Includes (i) unvested restricted shares which total 4,400 shares of stock from an initial grant of 4,400 shares of restricted stock made on March 11, 2013; (ii) unvested restricted shares and fully vested shares which total 4,200 shares of stock from an initial grant of 4,800 shares of restricted stock made on March 7, 2012 and (iii) unvested restricted shares and fully vested shares which total 3,315 shares of stock from an initial grant of 4,100 shares of restricted stock made on March 25, 2011. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Russell Glenn Allen
2013-04-01